LLY LLY
Eli Lilly's Oral Weight-Loss Drug Orforglipron Succeeds in Late-Stage Diabetes Trials
Eli Lilly and Company (NYSE: LLY) announced on October 15, 2025, that its experimental oral GLP-1 drug, orforglipron, achieved its primary and key secondary...
Lilly Endowment Sells a Portion of its Eli Lilly and Company Shares
On October 15, 2025, it was reported that the Lilly Endowment Inc. sold 3,658 shares of Eli Lilly & Co. common stock for a total of $3.16 million. The...
Eli Lilly's Stock Rating Upgraded to 'Buy' by Erste Group Bank
On October 14, 2025, analysts at Erste Group Bank upgraded their rating for Eli Lilly and Company (NYSE: LLY) from "hold" to "buy". This positive revision...
Eli Lilly to Unveil Key Overall Survival Data for Verzenio at ESMO 2025
Eli Lilly and Company announced it will present new clinical data from its oncology portfolio at the European Society for Medical Oncology (ESMO) Annual...
Eli Lilly to Present Key Oncology Data at ESMO 2025
Eli Lilly and Company announced on October 13, 2025, that it will present new data from its oncology portfolio at the European Society for Medical Oncology...
Eli Lilly to Unveil Key Overall Survival Data for Breast Cancer Drug Verzenio at ESMO 2025
On October 13, 2025, Eli Lilly and Company announced it will present new clinical data from its oncology portfolio at the European Society for Medical Oncology...
Eli Lilly and Partner Roche Gain FDA Approval for Alzheimer's Blood Test
Eli Lilly and Company, in partnership with Roche, has received clearance from the U.S. Food and Drug Administration (FDA) for their blood test designed to aid...
Eli Lilly to Invest Over $1 Billion in India to Expand Manufacturing and Supply Chain
Eli Lilly and Company announced on October 6, 2025, a significant investment of over $1 billion into new contract manufacturing in India. The investment...
Eli Lilly Announces New Phase 2 Study for Type 2 Diabetes Drug LY3938577
Eli Lilly and Company provided an update on a new Phase 2 clinical trial for its experimental Type 2 diabetes drug, LY3938577. The randomized, open-label,...
Eli Lilly to Invest Over $1 Billion in Indian Manufacturing Partnerships
Eli Lilly and Company announced it will invest over $1 billion in contract manufacturing partnerships in India to increase the global supply of its drugs for...